Topical beta-blocker therapy is a safe treatment for patients that meet a certain criteria
Practice Focus » Head and Neck
The decision is one of the greatest debates within maxillofacial trauma
Targeted therapy shows promise in clinical trials for both pediatric and adult patients
Overall 12% of patients experienced complications specific to the surgery within a year following the procedure.
In addition to the known sex-specific cancer types, such as ovarian and prostate cancers, there are significant gender disparities in non-sex-specific cancers, such as rate of incidence and susceptibility, tumor aggressiveness, prognosis, and treatment response. A recent study published in Cancer Cell explored the molecular basis for these differences (Cancer Cell. 2016;29:711-722). Although the medical […]
The American Cancer Society (ACS) has issued a new guideline that addresses the long-term needs of survivors of head and neck cancer.